Acadia Pharmaceuticals (ACAD) Share-based Compensation Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.70% |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | 29.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.16% |
| Dec 31, 2025 | 26.65% |
| Sep 30, 2025 | -49.63% |
| Jun 30, 2025 | -8.58% |
| Mar 31, 2025 | -22.85% |
| Dec 31, 2024 | -42.02% |
| Sep 30, 2024 | 41.13% |
| Jun 30, 2024 | 3.50% |
| Mar 31, 2024 | 0.31% |
| Dec 31, 2023 | 25.04% |
| Sep 30, 2023 | 1.24% |
| Jun 30, 2023 | -26.12% |
| Mar 31, 2023 | -1.72% |
| Dec 31, 2022 | 11.91% |
| Sep 30, 2022 | 17.79% |
| Jun 30, 2022 | -6.78% |
| Mar 31, 2022 | 13.49% |
| Dec 31, 2021 | -39.23% |
| Sep 30, 2021 | -27.26% |
| Jun 30, 2021 | 12.81% |
| Mar 31, 2021 | -41.01% |
| Dec 31, 2020 | 7.25% |
| Sep 30, 2020 | -2.96% |
| Jun 30, 2020 | -4.48% |
| Mar 31, 2020 | 12.40% |
| Dec 31, 2019 | -3.13% |
| Sep 30, 2019 | 9.19% |
| Jun 30, 2019 | -0.63% |
| Mar 31, 2019 | -2.73% |
| Dec 31, 2018 | -7.35% |
| Sep 30, 2018 | 2.39% |
| Jun 30, 2018 | 12.65% |
| Mar 31, 2018 | 31.28% |
| Dec 31, 2017 | 42.81% |
| Sep 30, 2017 | 40.61% |
| Jun 30, 2017 | 31.41% |
| Mar 31, 2017 | 30.25% |
| Dec 31, 2016 | 73.20% |
| Sep 30, 2016 | 51.20% |
| Jun 30, 2016 | 85.13% |
| Mar 31, 2016 | -17.71% |
| Dec 31, 2015 | 91.65% |
| Sep 30, 2015 | 582.25% |
| Jun 30, 2015 | 74.40% |
| Mar 31, 2015 | 359.46% |
| Dec 31, 2014 | 113.66% |
| Sep 30, 2014 | 13.07% |
| Jun 30, 2014 | 290.91% |
| Mar 31, 2014 | 443.30% |
| Dec 31, 2013 | 294.56% |
| Sep 30, 2013 | 146.11% |
| Jun 30, 2013 | 130.13% |
| Mar 31, 2013 | 40.92% |
| Dec 31, 2012 | 35.05% |
| Sep 30, 2012 | 21.70% |
| Jun 30, 2012 | 15.74% |
| Mar 31, 2012 | 10.13% |
| Dec 31, 2011 | 21.43% |
| Sep 30, 2011 | 201.50% |